Test ID USTEK Ustekinumab Quantitation with Antibodies, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Draw blood immediately before the next dose of drug administration (trough level).
2. Centrifuge and aliquot serum into a plastic vial.
Forms
If not ordering electronically, complete, print, and send 1 of the following with the specimen:
-Gastroenterology and Hepatology Test Request (T728)
-Therapeutics Test Request (T831)
Useful For
Evaluation of loss of response to therapy
Quantification of ustekinumab in human serum
Trough level quantitation for evaluation of patients treated with ustekinumab
Detection of antibodies to ustekinumab in human serum
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
USQN | Ustekinumab QN, S | No | Yes |
USTAB | Ustekinumab Ab, S | No | Yes |
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name
Ustekinumab QN with Antibodies, SSpecimen Type
SerumSpecimen Minimum Volume
0.35 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 21 days | |
Frozen | 21 days |
Reference Values
USTEKINUMAB QN, S:
Limit of quantitation is 0.3 mcg/mL
In inflammatory bowel disease, at post-induction measurement (week 8), concentrations above 3.5 mcg/mL are associated with good outcomes.
For maintenance stages:
Concentrations ≥1.0 mcg/mL are associated with clinical response and clinical remission
Concentrations ≥4.5 mcg/mL are associated with mucosal healing
USTEKINUMAB AB, S:
Limit of quantitation is 10 AU/mL
Absent: <10 AU/mL
Present: ≥10 AU/mL
Day(s) Performed
Monday, Wednesday, Friday
Report Available
2 to 5 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80299
83520
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
USTEK | Ustekinumab QN with Antibodies, S | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
USQN | Ustekinumab QN, S | 87408-1 |
USTAB | Ustekinumab Ab, S | 87409-9 |
Testing Algorithm
For more information see Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm.